FDA gives nod to BrainStorm for ALS trial after Phase III flop

Submitted by admin on April 9, 2024 - 11:39am

Source:

Clinical Trials Arena

News Tags:

BrainStorm Cell Therapeutics

clinical trials

NurOwn

FDA

ALS

Headline:

FDA gives nod to BrainStorm for ALS trial after Phase III flop

snippet:

BrainStorm Cell Therapeutics will be initiating a Phase IIIb confirmatory trial of its lead candidate NurOwn after discussions with the US Food and Drug Administration (FDA) following a previous Phase III failure.

Search form

You are here

FDA gives nod to BrainStorm for ALS trial after Phase III flop

FDA gives nod to BrainStorm for ALS trial after Phase III flop